Job Overview

Summary

Become a part of the Department that touches the lives of every American!  At the Department of Health and Human Services (HHS) you can give back to your community, state, and country by making a difference in the lives of Americans everywhere.  It is the principal agency for protecting the health of citizens.  Join HHS and help to make our world healthier, safer, and better for all Americans.

Who May Apply:  Federal employees with career or career-conditional appointments in the competitive service; former Federal employees with reinstatement eligibility based on previous career or career-conditional appointments; displaced Federal employees requesting special priority selection consideration under the Career Transition Assistance Plan (CTAP) and the Interagency Career Transition Assistance Program (ICTAP); veterans who are preference eligibles or who have been separated under honorable conditions after 3 years or more of continuous active service; Military Spouses; PHS Commissioned Corps Officers; and individuals with disabilities.

This position is located in the Department of Health and Human Services (DHHS), Food and Drug Administration (FDA), Center for Tobacco Products (CTP), Office of Science (OS), in Rockville, MD.

This vacancy is also being announced concurrently with vacancy announcement HHS-FDA-CTP-DE-13-900641 under competitive procedures.  Please review that announcement to see if you are eligible for consideration under competitive procedures.  NOTE:  Applicants must apply separately for each announcement in order to be considered.


This announcement may be used to fill multiple positions in multiple locations.

Duties

Develops products for each phase of risk assessment ( problem formulation, hazard identification, exposure assessment, hazard characterization, dose-response assessment and/or risk characterization), and encompass calculation techniques such as exposure estimation, dose estimation, risk aggregation, and/or basic statistical analysis.  Employs computer simulation modeling in support of risk assessments, including but not limited to,  techniques such as calculation of particle deposition, dosimetry estimation, physiologically-based pharmacokinetic (PBPK) modeling, biologically-based dose-response (BBDR) modeling, Monte Carlo simulation, or quantitative structure activity relationships (QSARs).